Intralesional 8.33% Rifamycin Infiltration; New Treatment for Cutaneous Leishmaniasis

Conclusion Rifamycin 8.33% solution given intralesionally in cutaneous leishmaniasis is a highly effective agent with a success rate of 92.7%. For cure, it needs 2-5 local infiltrations given every two weeks. In addition to be effective, its safe, and less costly therapeutic option for cutaneous leishmaniasis.
Source: Journal of Dermatology and Dermatologic Surgery - Category: Dermatology Source Type: research